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MaBACKGROUND Looking for and treating the portal of entry (POE) of infective endocarditis (IE) is important, but
published research on this topic is nonexistent.
OBJECTIVES The goal of this study was to systematically search for the POEs of present and potentially new episodes
of IEs.
METHODS Patients were systematically seen by a stomatologist, an ear, nose, and throat specialist, and a urologist;
women were systematically seen by a gynecologist; patients were seen by a dermatologist when there were cutaneous
and/or mucous lesions. Colonoscopy and gastroscopy were performed if the microorganism came from the gastroin-
testinal tract in patients $50 years of age and in those with familial histories of colonic polyposis. Treatment of the POE
was systematically considered.
RESULTS The POEs of the present IE episodes were identiﬁed in 74%of the 318 included patients. Themost frequent POE
was cutaneous (40% of identiﬁed POEs). It was mainly (62% of cutaneous POEs) associated with health care and with
intravenous drug use. The second most frequent POE was oral or dental (29%). A dental infectious focus was more often
involved (59%of oral or dental POEs) than a dental procedure (12%). POEswere gastrointestinal in 23%of patients. Colonic
polyps were found in one-half of the patients and colorectal adenocarcinomas in 14%. Performance was good regarding
the search for an oral or dental or a colonic potential POE, which were found in 53% and 40% of patients, respectively.
CONCLUSIONS Our search for the POEs of present IEs was often successful, as was searching for an oral or dental or a
gastrointestinal POE of a new IE episode. We advise the systematic performance of stomatologic examinations in patients
with IE and performance of colonoscopy in patients $50 years of age or at high risk for colorectal cancer.
(J Am Coll Cardiol 2016;67:151–8) © 2016 by the American College of Cardiology Foundation.I nfective endocarditis (IE) is a severe disease,with an in-hospital mortality rate of about20% (1). Five percent to 10% of patients will
have additional episodes of IE (2). Thus, looking for-
and treating the portal of entry (POE) of IE is particu-
larly important. The POE of the present episode must
be identiﬁed in order to treat it. The potential POE
of a new episode must be searched for in order to erad-
icate it and thus lower the risk for a new IE episode.
Yet published research on this topic is nonexistent.m the *Department of Cardiology, Hôpital Louis Pradel, Hospices Civils
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nuscript received July 27, 2015; revised manuscript received October 5, 2The search for and treatment of the POE are not
even mentioned in the most recent guidelines on IE
(3,4). We thus undertook a study of the performance
of a systematic search for the POE of the present
episode of IE and of a potential new episode of IE.
METHODS
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TABLE 1 Habitat and Potential
Microorganisms
Streptococci
Oral streptococci
Group mitis/salivarius (e.g., S.
sanguinis, parasanguinis, g
mutans, salivarius)
Group milleri (S. intermedius,
constellatus, anginosus)
Group D streptococci
S. bovis group (including S. ga
subsp. gallolyticus)
Enterococcus faecalis, Enteroc
Group B streptococci (S. agalact
Group C and G streptococci
Group C (S. dysgalactiae, S. eq
S. zooepidemicus)
Group C
Group A streptococci (S. pyogen
Streptococcus pneumoniae
Deﬁcient streptococci (Granulica
[Abiotrophia] defectiva)
Streptobacillus moniliformis
Staphylococci
Staphylococcus aureus
Coagulase-negative staphylococ
S. saprophyticus
S. epidermidis, capitis, haemol
hominis, saprophyticus, sch
lugdunensis, among others
ABBR EV I A T I ON S
AND ACRONYMS
ENT = ear, nose, and throat
IE = infective endocarditis
POE = portal of entry
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152hospital for deﬁnite IE according to the
Duke-Li criteria (5). Since then, we have
been systematically looking for the POE of
the present IE episode and for the potential
POE of a new IE episode (e.g., a patient’sSEE PAGE 159present IE is due to Streptococcus gallolyticus, the
POE of the present IE episode is a colorectal
adenocarcinoma, systematic stomatologic examina-
tion identiﬁes several dental infectious foci, which
are considered potential POEs for a new IE episode).
Patients were informed of the study but did not
have to provide individual consent, in accordance
with French ethics laws.
Patients were systematically seen by a stomatolo-
gist (who performed an orthopantomogram), an ear,
nose, and throat (ENT) specialist, and a urologist;Portals of Entry of the Causative Microorganisms of Infective
Habitat
sanguis,
ordonii, mitis, oralis,
Dental plaque, tongue, oral mucosa,
oropharynx (Online Refs. 1–6)
Oropharynx, subgingival plaque, GI tract,
vagina (S. anginosus) (Online Refs. 1,1
llolyticus GI tract (Online Refs. 7,15,16)
occus faecium GI tract, GU tract (Online Refs. 7,15)
iae) Oral mucosa, GI tract, vagina, anterior
urethra (Online Refs. 1,22)
ui, S. equisimilis, Nasopharynx, skin, GU tract (Online Ref.
Nasopharynx, skin, GU tract (Online Ref.
es) Oropharynx, skin (Online Ref. 26)
Nasopharynx (Online Ref. 28)
tella Oral microbiota, dental plaque (Online Re
Oral cavity of rats, gerbils, mice,
guinea pigs (Online Refs. 33,34)
Major sites: anterior nares, pharynx, perin
Minor sites: skin, intestine (Online Refs. 1
ci
Perineal area (Online Ref. 41)
yticus,
leiferi,
Skin (Online Refs. 1,43)women were systematically seen by a gynecologist.
When there were cutaneous or perioriﬁcial mucous
lesions on the initial examination, patients were
seen by a dermatologist. Cerebral and thor-
acoabdominopelvic scans were systematically per-
formed. Colonoscopy and gastroscopywere performed
if the microorganism came from the gastrointestinal
tract, in patients $50 years of age, and in those
with familial histories of colonic polyposis. Because
our center is a tertiary center with cardiac surgery
facilities, most patients who are hospitalized for IE
at our hospital are transferred from other hospitals.
Either the whole antibiotic course and all inves-
tigations for the search for the POE were performed
during the patient’s stay in our hospital, or the
patient was transferred to the hospital of origin
before the end of the antibiotic course, and we
requested that these investigations be performed
there.Endocarditis*
Portals of Entry
Dental and periodontal diseases (Online Refs. 7–9)
0–12)
Dental, periodontal or GI diseases, vaginal infection
(uncommon) (Online Refs. 7,8,10,13,14)
Colorectal adenoma and adenocarcinoma
(S. gallolyticus subsp. gallolyticus þþ)
(Online Refs. 8,16–20), biliary tract, GI tract
Invasive procedures of the GU tract,
including cystoscopy, lithotripsy, prostatectomy,
cesarean section, curettage (Online Refs. 15,21)
Colic tumors (benign or malignant) (Online Ref. 7),
bacterial translocation from the GI tract
(Online Ref. 22), soft-tissue infection,
GU tract infection, drug injection (Online Ref. 23)
2) Skin and respiratory tract infections, drug injection
(Online Refs. 7,24)
2) Peripartum GU infections (Online Ref. 25)
Skin and soft tissue infections, pharyngitis,
endometritis (Online Ref. 27)
Pneumonia, otitis media (Online Ref. 29)
fs. 2,30) Drug injection, periodontitis (Online Refs. 31,32)
Rat bite or abrasions (Online Refs. 34–36)
eal area
,37)
Health care–associated procedures, drug injection,
skin and soft-tissue infections (Online Refs. 7,38–41)
GU tract infections (Online Ref. 42)
Skin infections, health care–associated procedures
(Online Refs. 7,43)
Continued on the next page
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153For eachmicroorganism, themost probable POEwas
inferred from its natural habitat or site of colonization
in humans on the basis of a search of published
research (Table 1). Treatment, if any, of the POE was
systematically considered. It was either performed
during the patient’s stay in our hospital or prescribed.
Health care–associated IE was deﬁned as either IE
developing in a patient hospitalized for more than
48 h before the onset of signs or symptoms con-
sistent with IE or IE diagnosed within 48 h of
admission in an outpatient with extensive health care
contact (received intravenous therapy, wound care,TABLE 1 Continued
Microorganisms
HACCEK
Haemophilus spp., Aggregatibacter
(Actinobacillus) actinomycetemcomitans,
Capnocytophaga spp.,
Cardiobacterium hominis,
Eikenella corrodens,
Kingella kingae
Oropharynx (On
Intracellular bacteria
Coxiella burnetii Mammals (farm
parturient f
arthropods
Bartonella
B. henselae Cats (Online Re
B. quintana Unknown reser
Tropheryma whipplei Human GI tract
Legionella Water, especial
or artiﬁcial)
Brucella (B. melitensis, B. abortus, B. suis) Mammals (e.g.,
camel, buffa
Enterobacteria
E. coli, Salmonella spp., Enterobacter spp.,
among others
GI tract, perine
Miscellaneous bacteria
Corynebacterium diphteriae, C. jeikeium, C. striatum Environmental,
commensal
Pseudomonas spp. Environmental
Peptostreptococcus spp. Oropharynx, ch
Listeria spp. Environment (s
Propionibacterium spp. Oropharynx, sk
Atypical mycobacteria (e.g., M. chelonae,
M. fortuitum, M. chimaera)
Environment (w
animals, ine
Fungi and yeast
Aspergillus Environment
Candida Skin, GI tract
*See the Online Appendix for the list of references cited in this table.
GI ¼ gastrointestinal; GU ¼ genitourinary.or specialized nursing care at home within 30 days;
underwent hemodialysis; received intravenous
chemotherapy; resided in a nursing home or long-
term care facility). Community-acquired IE was
deﬁned as IE diagnosed at the time of admission (or
within 48 h of admission) in a patient not fulﬁlling
the criteria for health care–associated infection (6).
RESULTS
Among 444 patients hospitalized at our institution
between 2005 and 2011, 318 (320 episodes) wereHabitat Portals of Entry
line Refs. 7,44,50) Periodontitis, buccal and dental infections,
dental procedures, drug injection
(Online Refs. 7,44–49)
animals, especially
emales), birds, and
(ticks) (Online Ref. 51)
Inhalation or transcutaneous contact with
contaminated ﬂuids, ingestion of raw milk,
tick bites (Online Refs. 7,51,52)
f. 53) Cat scratch or bite, arthropod bite (Online Refs. 7,53,54)
voir beside humans (Online Ref. 53) Pediculus humanus corporis (Online Refs. 7,55)
(Online Refs. 57,58) Unknown (Online Refs.57,59)
ly warm water (natural
(Online Ref. 60)
Inhalation (Online Ref. 60)
cattle, sheep, goat,
lo) (Online Ref. 61)
Ingestion of raw milk, cutaneous contact,
or inhalation of contaminated ﬂuids (Online Ref. 61)
al area (Online Ref. 1) Health care–associated procedures, bacterial
translocation from the GI tract, drug injection
(Online Ref. 7), GU tract infections (E. coli)
(Online Ref. 62)
mucosa and skin
(Online Ref. 63)
Health care–associated procedures (catheter-related
infection, surgery, etc.), drug injection
(Online Refs.7,63)
(water) (Online Ref. 64) Drug injection, health care–associated invasive
procedures (Online Refs.7,64,65)
ronic skin lesions, GI tract, GU tract Periodontitis, gingivitis, diabetic foot (Online Ref. 66)
oil, water) (Online Ref. 7) Ingestion of contaminated food (Online Refs.7,67)
in (Online Refs.1,68) Health care–associated invasive procedures
(cardiothoracic surgery, catheter related
infections) (Online Refs.68,69)
ater, soil, plants,
rt surfaces) (Online Ref. 71)
Health care–associated invasive procedures
(cardiothoracic surgery), contaminated
bioprosthetic material (Online Refs.72–74)
Inhalation, cardiothoracic surgery (Online Ref. 70)
Health care–associated invasive procedures
(catheter related infections, surgery),
drug injection, cutaneous mycosis,
urinary tract infection (Online Refs. 7,75)
TABLE 2 Identiﬁed Portals of Entry in 238 Patients With
Infective Endocarditis
Portal of Entry
Cutaneous 96 (40)
Intravenous drug use 21
Nonintravenous drug use 75
Oral/dental 68 (29)
Gastrointestinal 56 (23)
Genitourinary 10 (4)
Ear, nose, and throat 5 (2)
Respiratory 3 (1)
Total 238 (100)
Values are n (%) or n.
TABLE 3
Health car
Vascula
n ¼
Infectio
Infectio
vasc
Communit
Domest
Nonsup
Diabetic
Occupat
Cutaneo
Venous
Pressure
Punctur
Insect b
Prurigo
Intravenou
Inoculatio
Values are n
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154included in the present study (we excluded 82 pa-
tients who died during hospitalization; 44 medical
charts were unavailable for technical reasons).
The median age of the patients was 61  2 years;
75% were men; 29% had native valve disease,
22% had $1 valvular prosthesis, and 49% did not
have previously known heart disease; 11% had
cardiac implantable electronic devices (pacemakers
or deﬁbrillators). Microorganisms were streptococci
in 41%, staphylococci in 31%, and enterococci
in 8%.
POE FOR THE PRESENT IE EPISODE. The POEs for
the present IE episodes were identiﬁed in 238 pa-
tients (74%). Among identiﬁed POEs, 40% were
cutaneous, 29% were oral or dental, and 23% were
gastrointestinal (Table 2).Cutaneous Portals of Entry of Infective Endocarditis
Portal of Entry
e–associated infective endocarditis 39 (41)
r access (central venous line, n ¼ 8; peripheral venous line,
5; subcutaneous implantable port, n ¼ 4)
17
n of a cardiac implantable electronic device 11
n of the operative site (cardiac valve replacement, n ¼ 6;
ular surgery, n ¼ 3; orthopedic surgery, n ¼ 2)
11
y-acquired infective endocarditis 33 (34)
ic wound by a sharp object 6
purative skin and soft-tissue infections 5
foot ulcer 5
ional hand wound 4
us abscess and furuncle 4
leg ulcer 3
ulcer 2
e wound (sea urchin, splinter) 2
ite 1
1
s drug use 21 (22)
n disease 3 (3)
or n (%).Cutaneous POE. POEs were cutaneous in 96 patients.
Cutaneous POEs were health care associated in 41% of
these patients, community acquired in 34%, related to
intravenous drug use in 22%, and related to inocula-
tion diseases in 3% (louse bite, Bartonella quintana,
n ¼ 1; tick bite, Coxiella burnetii, n ¼ 1; cat scratch
disease, Bartonella henselae, n ¼ 1).
Vascular access was the main health care–
associated cutaneous POE (44%), followed by infec-
tion of a cardiac implantable electronic device (28%)
and infection of the operative site (28%) (Table 3).
Wounds, nonsuppurative skin and soft-tissue in-
fections, and diabetic foot ulcers were the most
frequent community-acquired cutaneous POEs.
Staphylococci were responsible for 87% of the
39 cases of IE with health care–associated cutane-
ous POEs (Staphylococcus aureus, 38%; coagulase-
negative staphylococci, 49%) (Table 4). S. aureus
was responsible for 82% of 33 cases of IE with
community-acquired cutaneous POEs and for 52% of
cases of IE in intravenous drug users.
Oral or denta l POE. Overall, a stomatologist saw
62% of patients during their stays in our hospital. Oral
or dental POEs were identiﬁed in 68 patients. The
distribution of lesions is detailed in Table 5, and
the distribution of microorganisms is presented in
Table 6. Oral streptococci were responsible for 69% of
the cases of IE with oral or dental POEs.
Sixty-ﬁve of the 68 patients with oral or dental
POEs (96%) saw a stomatologist during their stay in
our hospital. For organizational reasons, the other
3 patients with oral or dental POEs did not see a
stomatologist during their hospital stays but had seen
their dentists within the previous 3 months.
Dental procedures to treat POEs were undertaken
during 24 patients’ stays in our hospital. All other
patients were given instructions on dental procedures
to be performed.
Gastro intest ina l POE. Gastrointestinal POEs were
identiﬁed in 56 patients. Colonic polyps were
present in 46% of these patients (Table 7). Colorectal
adenocarcinoma was diagnosed in 14% of the
patients. Streptococcus bovis group and Enterococcus
faecalis were responsible for 50% and 29% of
cases of IE with gastrointestinal POEs, respectively
(Table 8).
Other POE. Urinary POEs were acute pyelonephritis
(n ¼ 4), benign prostatic hypertrophy with acute urine
retention (n ¼ 1), transurethral resection of the pros-
tate (n ¼ 1), prostate needle biopsy (n ¼ 1), transure-
thral resection of bladder cancer (n ¼ 1), and urinary
self-probing because of chronic urethral stenosis
(S. bovis group, n ¼ 2; Enterococcus, n ¼ 1; Strepto-
coccus agalactiae, n ¼ 1; Escherichia coli, n ¼ 1).
TABLE 4 Microorganisms in Infective Endocarditis With a Cutaneous Portals of Entry
Microorganism
Health Care
Associated
Community
Acquired
Intravenous
Drug Use
Staphylococcus aureus 15 (MR, n ¼ 3) 27 (MR, n ¼ 1) 11 (MR, n ¼ 1)
Coagulase-negative staphylococci 19 (MR, n ¼ 8) 3
Enterococcus faecalis 3
Group G streptococci 1
Streptococcus agalactiae 1
Streptococcus dysgalactiae 1
Streptococcus pyogenes 1
Klebsiella spp. 1 (K. pneumoniae) 2 (K. oxytoca)
Propionibacterium spp. 1 (P. spp.) 1 (P. acnes)
Fungi 3
Serratia marcescens 1
No identiﬁed microorganism 2
MR ¼ methicillin resistant.
TABLE 5 Oral and Dental Portals of Entry of
Infective Endocarditis
Portal of Entry
Dental procedures in the previous 3 mo 8 (12)
Extraction 4 (6)
Scaling 1 (1)
Endodontic procedure 1 (1)
No details 2 (3)
Dental infectious focus (decay, fracture, traumatism) 9 (13)
Dental infectious focus with no more details 22 (32)
Periodontal disease 7 (10)
Endodontal and periodontal disease 12 (68)
Radiological dental infectious focus (cyst, granuloma)
without clinical lesion
9 (13)
Vigorous tooth brushing with frequent bleeding 1 (1)
Values are n (%).
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155One female patient had an infection (S. agalactiae)
of an aseptic necrobiosis of a uterine ﬁbroma. The
POE was ENT in 5 patients: pansinusitis with cerebral
abscesses (Streptococcus pneumoniae, n ¼ 1; Haemo-
philus parainﬂuenzae, n ¼ 1), tonsil phlegmon
(S. pneumoniae), recurrence of a laryngeal epidermoid
carcinoma (S. agalactiae), and repetitive epistaxis
with iterative plugging and cauterization of a nasal
polyp (S. aureus). Three patients had pneumonia, and
their blood cultures grew S. pneumoniae.
Nonident iﬁed POE. Among 82 episodes with non-
identiﬁed POEs, the microorganism habitat was
cutaneous in 49%, oral or dental in 22%, and gastro-
intestinal in 22% (Table 9).
POTENTIAL POE OF A NEW IE. Potential POEs for
future IE episodes were as follows:
 continuation of intravenous drug use in 21
patients;
 cutaneous disease in 2 patients: Klippel-Trenaunay
syndrome with varicose ulcer and psoriasis with
scratching lesions;
 oral or dental infective foci in 66 of 125 patients
(53%) who underwent stomatologic examinations:
dental infectious focus in 41, radiological dental
infectious focus (cyst, granuloma) without clinical
lesion in 9, endodontal and periodontal disease in
11, and periodontal disease in 5;
 colonic lesions (polyps, diverticulosis, adenocarci-
noma) in 32 of 80 patients (40%) who underwent
colonoscopy because they were $50 years of age or
had familial histories of colonic polyposis: polyps
in 13 patients, sigmoid diverticulosis in 15 patients,
sigmoid diverticulosis with polyps in 2 patients,
diffuse angiodysplasia in 1 patient, and colorectal
adenocarcinoma in 1 patient;
 urinary lesions in 11 of 52 patients (21%) who un-
derwent urinary examinations: prostate cancer in
3 patients, benign prostatic hypertrophy with
urine retention in 2 patients, urethral stenosis in
2 patients, pyelonephritis in 1 patient, cystinuria
with repetitive renal lithiasis in 1 patient, post-
radiotherapy bladder in 1 patient, and extrinsic
urethral compression by colon cancer in 1 patients
(no gynecologic lesions were found in the
16 women >79 years of age who underwent gyne-
cologic examinations); and
 ENT lesions (sinusitis, otomastoiditis, and so on)
in 6 of 180 examinations.
DISCUSSION
It seems obvious that the POE in a patient with IE
should be searched for and eradicated, ideally duringthe initial stay, while the patient is receiving antibi-
otics. Many physicians probably look for and treat the
POEs in their patients with IE. Yet there is no
recommendation about the POE in recent guidelines
on IE (3,4), and there is almost never information on
the POE in reports of large series of IE.
At our institution, where the POE of IE is system-
atically searched for, the POEs of the current IE epi-
sodes were found in as many as three-quarters of
patients. We consider this very good performance and
an a posteriori justiﬁcation of the systematic search
for IE POE.
However, one might argue that the proportion of
patients (up to a quarter) for whom POEs were not
found is too high. The microorganisms were known in
almost all (81 of 82) episodes of IE for which the POEs
were not found (Table 9), and this may help uncover a
possible POE, even if it is not indubitably identiﬁed.
TABLE 6 Microorganisms in Infective Endocarditis With an Oral
or Dental Portal of Entry
Microorganisms
Oral (viridans) streptococci 47 (69)
HACCEK bacteria 7 (10)
Streptococcus pyogenes (group A streptococci) 1 (1)
Streptococcus pneumoniae 1 (1)
Streptococcus dysgalactiae 1 (1)
Gemella morbillorum 2 (3)
Granulicatella (Abiotrophia) defectiva 1 (1)
Bulleidia extructa 1 (1)
Peptostretococcus anerobius 1 (1)
Neisseria sicca 1 (1)
Acinetobacter spp. 1 (1)
Propionibacterium acnes 1 (1)
No identiﬁed microorganism 3 (4)
Values are n (%).
HACCEK ¼ Haemophilus spp., Aggregatibacter (Actinobacillus) actino-
mycetemcomitans, Capnocytophaga spp., Cardiobacterium hominis, Eikenella
corrodens, Kingella kingae.
TABLE 8 Microorganisms in Infective Endocarditis With
Gastrointestinal Portals of Entry
Microorganisms
Streptococcus bovis group (S. bovis, S. equinus,
S. gallolyticus, S. infantarius, S. pasteurianus,
S. lutetiensis)
28 (50)
Streptococcus agalactiae (group B streptococci) 3 (6)
Streptococcus dysgalactiae 1 (2)
Streptococcus salivarius 1 (2)
Enterococcus faecalis 16 (29)
Enterococcus faecium 3 (5)
Staphylococcus aureus 1 (2)
No identiﬁed microorganism 3 (5)
Values are n (%).
TABLE 9 Microorganisms in 82 Episodes of Infective
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156The most frequent POE was cutaneous (40% of
identiﬁed POEs). It was mainly (62%) associated with
health care and with intravenous drug use. The most
frequent microorganisms were staphylococci, which
were identiﬁed in 78% of episodes of IE with cuta-
neous POEs, as expected from their ecology (Table 1),
S. aureus in 55%, and coagulase-negative staphylo-
cocci in 23%.
The second most frequent POE was oral or dental
(29%). Among oral or dental POEs, a dental infectious
focus was much more often involved (59% of oral orTABLE 7 Gastrointestinal Portals of Entry of
Infective Endocarditis
Portal of Entry
Upper gastrointestinal tract 5 (9)
Esophageal ulcer 2 (4)
Antrum and fundus atrophy 1 (2)
Esophageal varices þ bulb ulcer 1 (2)
Gastrostomy 1 (2)
Lower gastrointestinal tract 51 (91)
Polyps 22 (39)
Unique, $1 cm 7 (12)
Multiple, $1 cm 5 (9)
Multiple, <1 cm 4 (7)
Multiple, size unknown 6 (11)
Colorectal adenocarcinoma 8 (14)
Sigmoid diverticulosis 11 (20)
Sigmoid diverticulosis þ multiple polyps, $1 cm 4 (7)
Diffuse angiodysplasia 2 (4)
Active ileitis 1 (2)
Deﬁnitive colostomy because of rectal cancer 2 (4)
Colonoscopy with resection of several polyps 1 (2)
Values are n (%).dental POEs) than dental procedures (12%). Peri-
odontal disease was involved in 28%. The most
frequent microorganisms were oral (viridans) strep-
tococci (69%), then HACCEK bacteria (Haemophilus
spp., Aggregatibacter [Actinobacillus] actinomycet-
emcomitans, Capnocytophaga spp., Cardiobacterium
hominis, Eikenella corrodens, and Kingella kingae)
(10%). The habitat of viridans streptococci is dental
plaque, oral mucosa, and the oropharynx. Their POEs
are dental and periodontal disease (Table 1) (7). The
oropharynx is the habitat of HACCEK organisms.
Their POEs are buccal and dental infections and dental
procedures (Table 1) (8).Endocarditis With Nonidentiﬁed Portals of Entry
Microorganisms
Microorganisms with cutaneous habitat 40 (49)
Staphylococcus aureus 23 (28)
(MR, n ¼ 3)
Coagulase-negative staphylococci 10 (12)
Propionibacterium (P. acnes, P. granulosum) 4 (5)
Corynebacterium spp. 3 (4)
Microorganisms with oral/dental habitat 18 (22)
Oral streptococci 12 (15)
HACCEK 2 (2)
Gemella spp. 2 (2)
Streptococcus pyogenes (group A streptococci) 1 (1)
Granulicatella (Abiotrophia) adiacens 1 (1)
Microorganisms with gastrointestinal habitat 18 (22)
Gastrointestinal streptococci 7 (8)
Streptococcus agalactiae (group B streptococci) 5 (6)
Tropheryma whipplei 3 (4)
Enterococci 2 (2)
Various microorganisms* 5 (6)
No identiﬁed microorganism 1 (1)
Values are n (%). *Streptococcus pneumoniae, n ¼ 3; Capnocytophaga canimorsus,
n ¼ 1; polymicrobial (group G Streptococcus þ Staphylococcus epidermidis), n ¼ 1.
Abbreviations as in Tables 4 and 6.
CENTRAL ILLUSTRATION Infective Endocarditis: Flowchart for Identiﬁcation and Treatment of Portal of Entry
Y N
Treatment of POE of current IE episode (within time of treatment of IE)
Treatment of potential POE to avoid future IE episodes (within or shortly after treatment of present IE)
Gastrointestinal
POE
Other
POE
Oral/dental
POE
Cutaneous (skin)
POE
Patient seen by stomatologist, ENT specialist, urologist, 
gynecologist (female patients) and dermatologist
if cutaneous/peri-orificial mucous lesions
Patient to undergo colonoscopy and gastroscopy
Patient seen by stomatologist, ENT specialist,
urologist, gynecologist (female patients)
and dermatologist if cutaneous/peri-orificial mucous lesions
Infer most probable portal of entry (POE) from microorganism’s natural habitat
or site of colonization in a human on the basis of a literature search
Identify culprit microorganism(s) through blood cultures, serologies, and molecular methods
Patient ≥50 years old or with personal/familial history of colonic cancer?
Patient with Infective Endocarditis (IE) 
Delahaye, F. et al. J Am Coll Cardiol. 2016; 67(2):151–8.
The strategy of investigations and treatment of the portal of entry (POE) for the current episode of infective endocarditis (IE) and those for future episodes of IE is
shown according to the etiologic diagnosis of IE. ENT ¼ ear, nose, and throat; N ¼ no; Y ¼ yes.
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157The third most frequent POE was gastrointestinal
(23%). Colonic polyps were found in almost one-half
of the patients and colorectal adenocarcinoma in
14%. As may be expected, the most frequent
responsible microorganisms were S. bovis group
(S. gallolyticus) (50%) and E. faecalis (29%). The
habitat of the S. bovis group is the gastrointestinal
tract, and its POEs are colorectal adenoma and
adenocarcinoma. The habitat of enterococci is the
gastrointestinal and genitourinary tracts, and its
POEs are the biliary tree and gastrointestinal or
urinary tract infections (9) (Table 1).
Concordance between POE and microorganisms
(i.e., intravenous drug use and S. aureus, dentalinfection and viridans streptococci, colonic polyps
and S. bovis group) was excellent. But the POE should
not be only presumed because of the microorganism.
It should be looked for and treated, if needed.
Potential POEs for additional IE episodes were
obvious in drug users continuing drug use and in
some patients with chronic cutaneous lesions. The
performance of a systematic search for potential POE
was low for the ENT region and the genitourinary
tract. Performance was good regarding the search for
oral or dental or colonic potential POEs, which were
found in 53% and 40% of patients, respectively.
We limited systematic colonoscopy to patients who
had familial histories of colonic polyposis or were
PERSPECTIVES
COMPETENCY IN PATIENT CARE AND
PROCEDURAL SKILLS: A systematic search can
identify the source of bacteremia in three-quarters of
patients with IE, and in more than one-third of cases,
additional potential POEs can be found that pose a
risk for future infections.
TRANSLATIONAL OUTLOOK: Additional studies
could be conducted to conﬁrm these ﬁndings and
assess the efﬁcacy of eradicating potential portals of
bacterial entry for the prevention of recurrent
endocarditis.
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158$50 years of age, because the incidence of colorectal
cancer increases in patients aged $50 years (10).
Our study showed that with a systematic
approach to source identiﬁcation, the POE can often
be identiﬁed, and in a substantial proportion of
these patients, risk modiﬁcation can be attempted.
This topic is of clinical importance, as it relates to
our understanding of the sources of infection in
patients with IE and also inﬂuences management of
patients (e.g., ordering colonoscopy in a patient with
S. bovis group IE, recommending better maintenance
of oral hygiene).
STUDY LIMITATIONS. The present study was per-
formed at a single center; thus, the results may not be
applicable to other areas of the world. A POE can be
established with certainty only when the microor-
ganism responsible for IE is also identiﬁed at the site
of the POE and is genetically the same. Thus, the
POEs in our study were presumed, not deﬁnite.
CONCLUSIONS
A systematic search for the POEs of IE was successful
in as many as 74% of patients. Systematically
searching for potential oral or dental, gastrointes-
tinal, or genitourinary POEs of new IE episodes was
also successful in many patients.We would advise the systematic performance of a
stomatologic examination in patients with IE and
performance of colonoscopy in patients $50 years of
age or at high risk for colorectal cancer. A ﬂowchart
for the identiﬁcation and treatment of POEs is shown
in the Central Illustration.
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